Andrew Louden, M.S., Ph.D.
Dr. Andrew Louden is a program officer for the National Institute on Minority Health and Health Disparities (NIMHD). As a program officer, he helps to manage and develop the growing and diverse health services research portfolio at NIMHD. Before coming to NIMHD, he worked as a Scientific Review Officer at the Agency for Healthcare Research and Quality, where his responsibilities included providing policy direction and coordination for the planning and execution of the scientific and technical review of applications within the discipline of patient safety and quality improvement research. Dr. Louden also served previously as a program officer at the National Institute of Justice.
Dr. Louden’s research interests include patient safety, social determinants of health, the impact of the opioid epidemic in disparity populations, modeling and simulation, surgical disparities, patient-provider communication, health care access, and health care outcomes.
Dr. Louden received the B.A. degree in biology from Swarthmore College. He received the M.S. and Ph.D. degrees in genetics from Howard University. His research background includes molecular biology and virology.
- Louden, A and Lichy, J. Characterization of the MAP Kinase Inhibition Domain of ST5 p70, (2009) Saarbrücken, Germany: VDM Verlag Dr. Müller Aktiengesellschaft & Co. KG.
- Yi, Y., Singh, A., Shaheen, F., Louden, A., Lee, C and Collman, R. “Contrasting Use of CCR5 Structural Determinants by R5 and R5X4 Variants Within an HIV-1 Primary Isolate Quasispecies.” J. Virol. 77(22):12057-12066, 2003.
- Louden, A., Singh, A., Letvin, N., Sodroski, J. and Collman, R. Construction and Analysis of an R5-tropic SHIV 89.6. “HIV Vaccine Development: Immunological and Biological Challenges.” Banff, Alberta, Canada, 2003.
- Louden, A. and Lichy, J.L. Identification of the MAP Kinase Inhibition Domain of ST5 p70. “Howard University Medical Center Scientific Research Forum.” Washington, DC, 2001.